2 Safety
MIRUS Controller, SW 2.03.02, Additional Information Master (en-GB)
2-7
The use of volatile anaesthetics can affect the haemodynamic status of a patient and put
him/her at risk.
Ensure cardiovascular monitoring of the patient.
An elevated airway resistance may endanger the patient.
Monitor the patient's airway resistance.
Monitor the MIRUS Filter for occlusion or accumulation of patient secretions, and replace
when necessary.
2.1.11 Alarms
If alarm signals are not heard or seen, this may pose a risk to the patient.
Before each use, check the functioning of the visual and acoustic alarm signals during
the system test.
The user must remain within hearing range of the acoustic alarm signal.
Set the alarm volume to such a level that the alarm signals can be heard.
Always keep the display and alarm lights unobstructed.
If the alarm thresholds are not correctly adjusted in relation to the application and the patient,
this may pose a risk to the patient.
Always set the alarm thresholds for
etVA and etCO
2
in accordance with the application
and dependent on the patient.
2.1.12 Transportation within the hospital
Transportation within the hospital to maintain an initiated inhalation sedation may put the
patient and other persons at risk.
Before transportation within the hospital, please ensure that the following prerequisites
have been satisfied:
•
an uninterruptible power supply is present,
•
a gas disposal system has been connected,
•
the MIRUS Controller is in a horizontal position,
•
the level of volatile anaesthetic is adequate.
Summary of Contents for Mirus MC DES
Page 1: ...Additional Information MIRUSTM Controller Software version 2 03 02 Hardware version 2 n...
Page 28: ...1 Introduction 1 22 MIRUS Controller SW 2 03 02 Additional Information Master en GB Notes...
Page 78: ...5 Operation 5 18 MIRUS Controller SW 2 03 02 Additional Information Master en GB Notes...